首页> 外文期刊>European journal of pharmaceutical sciences >Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (-)-epigallocatechin gallate.
【24h】

Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (-)-epigallocatechin gallate.

机译:壳聚糖纳米颗粒增强了绿茶儿茶素(+)-儿茶素和(-)-表没食子儿茶素没食子酸酯的肠吸收。

获取原文
获取原文并翻译 | 示例
           

摘要

Catechins found in green tea have received considerable attention due to their favourable biological properties which include cardioprotective, neuroprotective and anti-cancer effects. However, their therapeutic potential is limited by their low oral bioavailability, attributed to poor stability and intestinal absorption. We encapsulated (+)-catechin (C) and (-)-epigallocatechin gallate (EGCg) in chitosan nanoparticles (CS NP) as a means of enhancing their intestinal absorption. Using excised mouse jejunum in Ussing chambers, encapsulation significantly enhanced (p<0.05) intestinal absorption. The cumulative amounts transported after encapsulation were significantly higher (p<0.05), i.e. 302.1+/-46.1 vs 206.8+/-12.6ng/cm(2) and 102.7+/-12.4 vs 57.9+/-7.9ng/cm(2) for C and EGCg, respectively. The mechanism by which absorption was enhanced was not through an effect of CS NPs on intestinal paracellular or passive transcellular transport processes (as shown by transport of (14)C-mannitol and (3)H-propranolol) or an effect on efflux proteins (as shown by transport of (3)H-digoxin) but was likely due to stabilization of catechins after encapsulation (99.7+/-0.7 vs 94.9+/-3.8% and 56.9+/-3.0 vs 1.3+/-1.7% of the initial C and EGCg concentration remaining, respectively). This study demonstrates that encapsulation of catechins in CS NPs enhances their intestinal absorption and is a promising strategy for improving their bioavailability.
机译:绿茶中的儿茶素因其良好的生物学特性(包括心脏保护,神经保护和抗癌作用)而受到了广泛关注。然而,由于低的口服生物利用度,其治疗潜力受到限制,这归因于稳定性和肠道吸收差。我们将(+)-儿茶素(C)和(-)-表没食子儿茶素没食子酸酯(EGCg)封装在壳聚糖纳米颗粒(CS NP)中,作为增强其肠道吸收的手段。在Ussing小室中使用切除的小鼠空肠,包囊显着增强了(p <0.05)肠道吸收。封装后的累积运输量显着更高(p <0.05),即302.1 +/- 46.1与206.8 +/- 12.6ng / cm(2)和102.7 +/- 12.4与57.9 +/- 7.9ng / cm(2) )分别用于C和EGCg。吸收增强的机制不是通过CS NP对肠旁细胞或被动跨细胞转运过程的影响(如(14)C-甘露醇和(3)H-普萘洛尔的转运所显示的)或对外排蛋白的影响(如(3)H-地高辛的转运所显示的),但可能是由于包封后儿茶素的稳定(99.7 +/- 0.7对94.9 +/- 3.8%和56.9 +/- 3.0对1.3 +/- 1.7%)剩余的初始C和EGCg浓度)。这项研究表明,儿茶素在CS NP中的包封可增强其肠道吸收,并且是提高其生物利用度的有前途的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号